HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sándor Turkevi-Nagy Selected Research

Syntaxin 1

4/2021The panel of syntaxin 1 and insulinoma-associated protein 1 outperforms classic neuroendocrine markers in pulmonary neuroendocrine neoplasms.
2/2020Syntaxin 1: A Novel Robust Immunophenotypic Marker of Neuroendocrine Tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sándor Turkevi-Nagy Research Topics

Disease

2Neoplasms (Cancer)
09/2021 - 04/2021
2Insulinoma
04/2021 - 01/2021
1Acute Kidney Injury (Acute Renal Failure)
01/2022
1Gallbladder Neoplasms (Gallbladder Cancer)
09/2021
1Carcinoma (Carcinomatosis)
04/2021
1Carcinoid Tumor (Carcinoid)
04/2021
1Breast Neoplasms (Breast Cancer)
01/2021
1Neuroendocrine Tumors (Neuroendocrine Tumor)
02/2020

Drug/Important Bio-Agent (IBA)

2Chromogranin AIBA
04/2021 - 01/2021
2Syntaxin 1IBA
04/2021 - 02/2020
2SynaptophysinIBA
04/2021 - 01/2021
2Proteins (Proteins, Gene)FDA Link
04/2021 - 01/2021
1Bile Pigments (Bilin)IBA
09/2021

Therapy/Procedure

1Extracorporeal Membrane Oxygenation
01/2022